Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jun T Oh

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Antimicrobial Agents and Chemotherapy|September 17, 2021
Correction for Oh et al., "Development of a Broth Microdilution Method for Exebacase Susceptibility Testing"Jun T Oh, Jane E Ambler, Cara Cassino, et al.
Antimicrobial Agents and Chemotherapy|April 27, 2021
Development of a Broth Microdilution Method for Exebacase Susceptibility TestingJun T Oh, Jane E Ambler, Cara Cassino, et al.
The Journal of Infectious Diseases|February 17, 2024
The Engineered Lysin CF-370 Is Active Against Antibiotic-Resistant Gram-Negative Pathogens In Vitro and Synergizes With Meropenem in Experimental Pseudomonas aeruginosa PneumoniaKaren Sauve, Aubrey Watson, Jun T Oh, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Antimicrobial Agents and Chemotherapy|September 17, 2021
Correction for Oh et al., "Development of a Broth Microdilution Method for Exebacase Susceptibility Testing"Jun T Oh, Jane E Ambler, Cara Cassino, et al.
Antimicrobial Agents and Chemotherapy|April 27, 2021
Development of a Broth Microdilution Method for Exebacase Susceptibility TestingJun T Oh, Jane E Ambler, Cara Cassino, et al.
The Journal of Infectious Diseases|February 17, 2024
The Engineered Lysin CF-370 Is Active Against Antibiotic-Resistant Gram-Negative Pathogens In Vitro and Synergizes With Meropenem in Experimental Pseudomonas aeruginosa PneumoniaKaren Sauve, Aubrey Watson, Jun T Oh, et al.
Pageof 1